GL Pharm Tech Corp. (KOSDAQ:204840)
4,230.00
+25.00 (0.59%)
At close: Aug 24, 2026
GL Pharm Tech Revenue
GL Pharm Tech had revenue of 9.70B KRW in the quarter ending June 30, 2026, with 16.06% growth. This brings the company's revenue in the last twelve months to 38.21B, up 29.75% year-over-year. In the year 2025, GL Pharm Tech had annual revenue of 35.27B with 35.40% growth.
Revenue (ttm)
38.21B
Revenue Growth
+29.75%
P/S Ratio
1.71
Revenue / Employee
1.16B
Employees
33
Market Cap
65.22B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 35.27B | 9.22B | 35.40% |
| Dec 31, 2024 | 26.05B | 14.93M | 0.06% |
| Dec 31, 2023 | 26.03B | 9.30B | 55.62% |
| Dec 31, 2022 | 16.73B | 4.30B | 34.63% |
| Dec 31, 2021 | 12.43B | 437.53M | 3.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Daehan Nupharm | 205.39B |
| Jin Yang Pharmaceutical | 124.61B |
| Sinsin Pharmaceutical | 118.65B |
| Hwail Pharmaceutical | 107.87B |
| KOREA PHARMA | 93.94B |
| Sinil Pharmaceutical | 82.18B |
| Sam-A Pharm. | 72.28B |
| Polaris AI Pharma | 63.94B |